New injection offers hope for men with chronic groin pain
NCT ID NCT05707208
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called ST-01, given as a shot into the spermatic cord every 28 days, to see if it safely reduces chronic scrotal pain better than standard lidocaine. 63 men with pain lasting over 3 months took part. The main goal was to measure pain changes using a 0-10 scale over 56 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 2
Tests whether the treatment actually works, and watches for side effects, in a larger group.
- Participants
-
63 people
The number who actually took part.
- Started
-
Mar 2023
- Finished
-
Jan 2026
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adult (≥ 19 years) male 2. Unilateral or bilateral scrotal pain lasting \> 3 months 3. Have nociceptive scrotal pain 4. Average daily maximum scrotal pain score over 7 days ≥ 4 on the 0-10 NRS (Appendix 2). Participants with bilateral scrotal pain must be able to distinguish one side with pain score ≥ 4 and the opposite side must have a maximum scrotal pain score of ≤ 3.0 at baseline. 5. Positive response to test spermatic cord block with 1% lidocaine (Lidocaine Hydrochloride Injection, USP, 1%, 10 mg/mL), defined as a decrease in pain score of at least 2 within 1 hour of injection 6. Baseline blood levels without clinically significant abnormalities including liver function tests (alanine aminotransferase \[ALT\], aspartate aminotransferase \[AST\], gamma-glutamyl transferase \[GGT\], and alkaline phosphatase \[ALP\]) no greater than 50% above the upper limit of normal 7. If sexually active, is willing to use adequate birth control methods to prevent pregnancy over the course of the study Exclusion Criteria: 1. Negative response to test spermatic cord block, defined as absence of a decrease in pain score of at least 2 within an hour of injection 2. Other pain generator site with NRS pain score ≥ 4 that interferes with evaluation of scrotal pain 3. History of allergic reaction to lidocaine or any component of ST-01 4. Any contraindication to local anesthesia with lidocaine (e.g., known hypersensitivity to anesthetics of the amide type; hypokalemia, complete heart block, anticoagulants (aspirin permitted), antiarrhythmic medication.) 5. Active infection involving the urinary tract or scrotum 6. Inability to give consent 7. Inability to follow up according to the protocol 8. Negative response to previous spermatic cord block 9. Any other condition that the investigator believes may interfere with the safety of the participant, study conduct, or interpretation of the data.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic pain are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jonathan Giddens Medicine Professional Corporation
Brampton, Ontario, L6T 4S5, Canada
-
Kelowna General Hospital Clinical Research Department
Kelowna, British Columbia, V1Y 1T2, Canada
-
Men's Health Clinic Manitoba
Winnipeg, Manitoba, R3P 2S8, Canada
-
Mount Sinai Hospital - Men's Health Institute
Toronto, Ontario, M5T 3L9, Canada
-
Prostate Cancer Centre - Rockyview Hospital
Calgary, Alberta, T2V 1P9, Canada
-
THEO Medical
Montreal, Quebec, H3M 1L3, Canada
-
The Fe/Male Health Centre
Oakville, Ontario, L6H 3P1, Canada
-
Vancouver Prostate Centre
Vancouver, British Columbia, V5Z 1M9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One 2-Hour class may help new mothers manage Post-Cesarean pain
- Zapping deep brain regions to quiet chronic back pain
- Herbal injections at acupuncture points tested against physical therapy for Long-Lasting sciatica
- Can difficulty naming emotions shape how much tailbone pain you feel?
- Can talk therapy rewire the brain to ease burn Survivors' pain?
- Can a video game teach cancer patients to tame their pain?